Risk of mortality in alemtuzumab-treated MS patients vs. MS patients treated with other disease modifying therapies: Preliminary results of a feasibility analysis

Saved in:
Bibliographic Details
Main Authors: Magyari, M, Hillert, J, Glaser, A, Reinold, J, Hobart, J, Hosking, R, Coles, A, Brown, W, Robertson, N, Anderson, V, Htet, Z, Joensen, H, Mouresan, EF, Hakkarainen, K, Freilich, J, Benzerdjeb, H, Jurgensen, S, Sinnott, SJ, E, JY, Drahota, J, Horakova, D
Format: Conference Proceeding
Language:English
Subjects:
Medicin och hälsovetenskap
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1352-4585